Matching slides 118,471
Current window 82,621-82,650
Pages 3,950
Rows per page 30
Component: Paragraphclear collectionreset all

Component

82,621-82,650 of 118,471

filter-aware
245
The slide uses a Q&A format to highlight alleged safety violations and hospital staff complaints.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
247
The slide uses direct quotes to highlight operational risks and potential regulatory/ethical violations regarding the use of OCS specialists.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
248
The slide uses a Q&A transcript format to substantiate claims of poor management and safety negligence.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
250
The slide uses strong, emotive language to frame the company's leadership as the primary antagonist.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
252
The slide uses direct quotes from KOLs to build a negative narrative around the company's business ethics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
253
The slide uses highlighted text to emphasize key quotes from former executives regarding the CEO's professional conduct.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
255
The slide uses a combination of summary text and a direct quote to highlight unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
256
The slide uses a Q&A transcript format to substantiate a serious allegation of unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
259
The slide uses a Q&A format to document allegations of unethical sales pressure by a specific individual (Magdy Attia) at TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
261
The slide uses a Q&A format to highlight potential malpractice and coercion.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
262
The slide presents a narrative of a specific medical failure involving a necrotic liver, alleging that TransMedics may be concealing damage from receiving centers.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
263
The slide uses a Q&A format to highlight a specific allegation of corporate dishonesty.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
264
The slide uses a Q&A format to highlight a perceived cover-up by the company regarding device performance.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
265
The slide uses a quote to highlight a perceived lack of transparency by the company.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
266
The slide uses direct quotes to characterize the CEO as 'arrogant' and the company's behavior as 'extortion' and 'aggressive'.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
269
This appears to be a narrative slide from a research note or report, focusing on churn.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
270
The slide uses anecdotal evidence from a 'prominent surgeon' to support a bearish thesis on TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
271
The slide uses direct quotes from surgeons to build a narrative of financial unviability and institutional pushback against the product.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
272
The slide uses a Q&A format to directly contradict claims made by the TransMedics CEO regarding reimbursement pass-through.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
273
The slide uses direct quotes to build a narrative of customer churn and institutional resistance.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
276
The slide uses a Q&A format to highlight a specific expert's negative sentiment toward TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
277
The slide uses direct quotes from a high-volume TransMedics user to illustrate market vulnerability and the shift toward competitors offering more autonomy.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
278
The slide uses a Q&A format to build a narrative of market abandonment.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
281
This slide serves as a highly critical, accusatory statement against the subject company.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
282
The slide uses a testimonial from a transplant surgeon to support a bearish thesis on the company's market position.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
283
The slide uses direct quotes from KOLs to frame the company's technology as a commoditized, overpriced solution with no clinical advantage over traditional cold storage.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
285
The slide uses a 'villain critique' approach by aggregating expert opinions to undermine the company's value proposition.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
288
The slide uses a 'before-after' style comparison between a conceptual timeline and actual competitor hardware.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
290
The slide uses a Q&A format to highlight the perceived lack of value proposition for the OCS Lung product.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
291
The slide uses direct quotes from a surgeon to undermine the company's value proposition.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit